In vitro release kinetics and bioavailability of gastroretentive cinnarizine hydrochloride tablet

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 294-303

  Nagarwal, Ramesh C ^a   Ridhurkar, Devendra N ^b   Pandit, J K ^a  

^a BANARAS HINDU UNIVERSITY   (India)

^b Macleods Research and Development Center   (India)

Author keywords

Bioavailability; Cinnarizine HCl; Floating tablet; HPMC; Kinetic models

Indexed keywords

CINNARIZINE;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED DRUG RELEASE; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG ELIMINATION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG UPTAKE; HYDRATION; HYDROPHILICITY; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; STOMACH JUICE; STOMACH PH; SURFACE PROPERTY; SUSPENSION; TABLET; TIME TO MAXIMUM PLASMA CONCENTRATION; VISCOSITY;

ALGINATES; ANIMALS; BIOLOGICAL AVAILABILITY; CHEMISTRY, PHARMACEUTICAL; CINNARIZINE; EXCIPIENTS; FEMALE; GLUCURONIC ACID; HEXURONIC ACIDS; KINETICS; MALE; METHYLCELLULOSE; PHARMACEUTICAL PREPARATIONS; POLYMERS; RABBITS; SODIUM BICARBONATE; STOMACH; TABLETS; VISCOSITY; WATER;

EID: 77950918303     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9380-5     Document Type: Article

References (32)

1. IS Ahmed JW Ayres 2007 Bioavailability of riboflavin from a gastric retention formulation Int J Pharm 330 146 154 10.1016/j.ijpharm.2006.09.021 1:CAS:528:DC%2BD2sXntFSguw%3D%3D 17034968 (Pubitemid 46097370)
2. MF Williams GE Dukes W Heizer Y Han DJ Herman T Lampin, et al. 1992 Influence of gastrointestinal site of drug delivery on the absorption characteristics of ranitidine Pharm Res 9 1190 1194 10.1023/A:1015860007380 1:CAS:528:DyaK38XlvVChsbY%3D 1409403
3. SJ Hwang H Park K Park 1998 Gastric retentive drug-delivery systems Crit Rev Ther Drug Carrier Syst 15 243 284 9699081
4. S Desai S Bolton 1993 A floating controlled-release drug delivery systems: in vitro-in vivo evaluation Pharm Res 10 1321 1325 10.1023/A: 1018921830385 1:CAS:528:DyaK3sXmtleqsLc%3D 8234170 (Pubitemid 23261833)
5. AK Hilton PB Deasy 1992 In vitro and in vivo evaluation of an oral sustained-release floating dosage form of amoxycillin trihydrate Int J Pharm 86 79 88 10.1016/0378-5173(92)90033-X 1:CAS:528:DyaK38XmsFyisr4%3D
6. RS Matharu NM Singhavi 1992 Novel drug delivery system for captopril Drug Dev Ind Pharm 18 1567 1574 10.3109/03639049209040859 1:CAS:528: DyaK38XkvFOhtL4%3D
7. PR Sheth J Tossounian 1984 The hydrodynamically balanced system (HBSE): a novel drug delivery system for oral use Drug Dev Ind Pharm 10 313 339 10.3109/03639048409064653 1:CAS:528:DyaL2cXkt1yiurk%3D (Pubitemid 14137879)
8. GL Chen WH Hao 1998 In vitro performance of floating sustained-release capsule of verapamil Drug Dev Ind Pharm 24 1067 1072 10.3109/03639049809089950 1:CAS:528:DyaK1cXmsVanu78%3D 9876561
9. M Fukuda NA Peppas JW McGinity 2006 Floating hot-melt extruded tablets for gastroretentive controlled drug release system J Control Release 115 121 129 10.1016/j.jconrel.2006.07.018 1:CAS:528:DC%2BD28XhtVOgt73E 16959356 (Pubitemid 44537498)
10. Z Wei Z Yu D Bi 2001 Design and evaluation of a two-layer floating tablet for gastric retention using cisapride as a model drug Drug Dev Ind Pharm 27 469 474 10.1081/DDC-100104323 1:CAS:528:DC%2BD3MXltVKnurs%3D 11448055 (Pubitemid 32612737)
11. X Xiaoqiang S Minjie Z Feng H Yiqiao 2006 Floating matrix dosage form for phenoporlamine hydrochloride based on gas forming agent: in vitro and in vivo evaluation in healthy volunteers Int J Pharm 310 139 145 10.1016/j.ijpharm.2005. 12.003 (Pubitemid 43287977)
12. M Ichigawa S Watanabe Y Miyake 1991 A new multiple-unit oral floating dosage system. I: preparation and in vitro evaluation of floating and sustained-release characteristics J Pharm Sci 80 1062 1106 10.1002/jps. 2600801113
13. S Baumgartner A Tivadar F Vrečer J Kristl 2001 Development of floating tablets as a new approach to the treatment of Helicobacter pylori infections Acta Pharm 51 21 33 1:CAS:528:DC%2BD3MXislaru7o%3D (Pubitemid 32298023)
14. E Cedillo-Ramirez L Villafuerte-Robles A Hernandez-Leon 2006 Effect of added pharmatose DCL11 on the sustained-release of metronidazole from methocel K4M and carbopol 971 NF floating matrices Drug Dev Ind Pharm 32 955 965 10.1080/03639040500534127 1:CAS:528:DC%2BD28XhtVSktrjF 16954108 (Pubitemid 44359757)
15. SK Sopimath AR Kulkarni WE Rudzinski TM Aminabhavi 2001 Microspheres as floating drug delivery systems to increase gastric retention of drugs Drug Metab Rev 33 149 160 10.1081/DMR-100104401 (Pubitemid 32703254)
16. SM Hasan AF Elmosallamy AB Abbas 2002 LC and TLC determination of cinnarizine in pharmaceutical preparations and serum J Pharm Biomed Anal 28 711 719 10.1016/S0731-7085(01)00662-8 (Pubitemid 34465637)
17. DS Roy BD Rohera 2000 Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices Eur J Pharm Sci 16 193 199
18. NK Ebube AH Hikal AB Jones 1997 Sustained release of acetaminophen from heterogeneous matrix tablets: influence of polymer ratio, polymer loading, and co-active on drug release Pharm Dev Technol 2 161 170 10.3109/10837459709022621 1:CAS:528:DyaK2sXjvVygsbg%3D 9552442
19. BY Choi HJ Park SJ Hwang JB Park 2002 Preparation of alginate beads for floating drug delivery system: effects of CO2 gas-forming agents Int J Pharm 239 81 91 10.1016/S0378-5173(02)00054-6 1:CAS:528:DC%2BD38XktFektr4%3D 12052693 (Pubitemid 34615797)
20. RK Parikh CP Parikh RR Delvadia SM Patel 2006 A novel multicompartment dissolution apparatus for evaluation of floating dosage form containing poorly soluble weakly basic drug Dissolution Technologies 13 14 19 1:CAS:528: DC%2BD28XjvVWktLY%3D
21. LS Wan PW Heng LF Wong 1993 Relationship between swelling and drug release in a hydrophilic matrix drug Dev Ind Pharm 19 1201 10.3109/ 03639049309063012 1:CAS:528:DyaK3sXis1Srtbc%3D
22. P Colombo R Bettini P Santi A Ascentiis NA Peppas 1996 Analysis of the swelling and release mechanisms from drug delivery systems with emphasis on drug solubility and water transport J Control Release 39 231 10.1016/0168-3659(95) 00158-1 1:CAS:528:DyaK28Xjt1yktbc%3D (Pubitemid 26194222)
23. K Mitchell JL Ford DJ Armstrong PN Elliot JE Hogan C Rostron 1993 The influence of drugs on the properties of gels and swelling characteristics of matrices containing methylcellulose or hydroxypropylmethylcellulose Int J Pharm 100 165 173 10.1016/0378-5173(93)90087-V 1:CAS:528:DyaK2cXjsl2ruw%3D%3D (Pubitemid 23316328)
24. G Yan H Li R Zhang D Ding 2000 Preparation and evaluation of a sustained-release formulation of nifedipine HPMC tablets Drug Dev Ind Pharm 26 681 686 10.1081/DDC-100101284 1:CAS:528:DC%2BD3cXjt1Cjsb0%3D 10826117 (Pubitemid 30317075)
25. S Conti L Maggi L Segale E Ochoa Machiste U Conte P Grenier, et al. 2007 Matrices containing NaCMC and HPMC: 1. Dissolution performance characterization Int J Pharm 333 136 142 10.1016/j.ijpharm.2006.11.059 1:CAS:528: DC%2BD2sXitV2qurw%3D 17207943 (Pubitemid 46283280)
26. R Harland A Gazzaninga M Sangalli P Colomb NA Peppas 1988 Drug/polymer matrix swelling and dissolution Pharm Res 5 488 10.1023/A:1015913207052 1:CAS:528:DyaL1cXlslKiurs%3D 3244656
27. J Bain S Tan D Gandarton M Solomon 1991 Comparison of the in vitro release characteristics of a wax matrix and a hydrogel sustained release diclofenac sodium tablet Drug Dev Ind Pharm 17 215 10.3109/03639049109043821 1:CAS:528:DyaK3MXhsFSjtbo%3D
28. DA Alderman 1984 A review of cellulose ethers in hydrophilic matrices for oral controlled-release dosage forms Int J Pharm 5 1 9 1:CAS:528: DyaL2MXksVantrw%3D
29. AC Hodson JR Mitchell MC Davies CD Melia 1995 Structure and behavior in hydrophilic matrix sustained release dosage forms: 3. The influence of pH on the sustained-release performance and internal gel structure of sodium alginate matrices J Control Release 33 143 152 10.1016/0168-3659(94)00076-7
30. C Costa CJM Lobo 2001 Modeling and comparison of dissolution profiles Eur J Pharm Sci 13 123 133 10.1016/S0928-0987(01)00095-1 1:CAS:528: DC%2BD3MXisF2qs78%3D 11297896 (Pubitemid 32288781)
31. EI Hasan BI Amro T Arafat AA Badwan 2003 Assessment of a controlled release hydrophilic matrix formulation for metoclopramide HCl Eur J Pharm Biopharm 55 339 344 10.1016/S0939-6411(03)00022-5 1:CAS:528:DC%2BD3sXjs1GjtLw%3D 12754009 (Pubitemid 36561561)
32. SK Paulson MB Vaughn SM Jessen Y Lawal CJ Gresk B Yan, et al. 2001 Pharmacokinetics of celecoxib after oral administration in dogs and humans: effect of food and site of absorption J Pharmacol Exp Ther 297 2 638 645 1:CAS:528:DC%2BD3MXjt1Wlsbw%3D 11303053 (Pubitemid 32377995)